16-28882455-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_004320.6(ATP2A1):c.329G>T(p.Arg110Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R110W) has been classified as Uncertain significance.
Frequency
Consequence
NM_004320.6 missense
Scores
Clinical Significance
Conservation
Publications
- Brody myopathyInheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP2A1 | NM_004320.6 | c.329G>T | p.Arg110Leu | missense_variant | Exon 5 of 23 | ENST00000395503.9 | NP_004311.1 | |
| ATP2A1 | NM_001286075.2 | c.-47G>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 3 of 21 | NP_001273004.1 | |||
| ATP2A1 | NM_173201.5 | c.329G>T | p.Arg110Leu | missense_variant | Exon 5 of 22 | NP_775293.1 | ||
| ATP2A1 | NM_001286075.2 | c.-47G>T | 5_prime_UTR_variant | Exon 3 of 21 | NP_001273004.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATP2A1 | ENST00000395503.9 | c.329G>T | p.Arg110Leu | missense_variant | Exon 5 of 23 | 1 | NM_004320.6 | ENSP00000378879.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251450 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461868Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Brody myopathy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 110 of the ATP2A1 protein (p.Arg110Leu). This variant is present in population databases (rs768820110, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with ATP2A1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at